These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19778661)

  • 1. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM; Segura J
    Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Global risk and objectives in cardiovascular diseases].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus.
    O'Neill SG; Pego-Reigosa JM; Hingorani AD; Bessant R; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2009 May; 48(5):573-5. PubMed ID: 19273540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the assessment of cardiac risk: beyond Framingham.
    Borden WB; Davidson MH
    Rev Cardiovasc Med; 2009; 10(2):63-71. PubMed ID: 19593318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for atherosclerotic disease: present and future.
    Vinereanu D
    Herz; 2006 Dec; 31 Suppl 3():5-24. PubMed ID: 17577934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do novel biomarkers add to existing scores of total cardiovascular risk?
    De Backer G; Graham I; Cooney MT
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):14-7. PubMed ID: 22801065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total cardiovascular disease risk assessment: a review.
    Cooney MT; Cooney HC; Dudina A; Graham IM
    Curr Opin Cardiol; 2011 Sep; 26(5):429-37. PubMed ID: 21822139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor management: antiatherogenic therapies.
    Gielen S; Sandri M; Schuler G; Teupser D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S29-36. PubMed ID: 19675434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India.
    Chow CK; Joshi R; Gottumukkala AK; Raju K; Raju R; Reddy S; Macmahon S; Neal B
    Am Heart J; 2009 Sep; 158(3):349-55. PubMed ID: 19699856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Why and how to measure cardiovascular risk?].
    Krummel T; Dervaux T; Parvès-Braun L; Hannedouche T
    Rev Prat; 2004 Mar; 54(6):615-7, 619, 621-25. PubMed ID: 15222612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk: its assessment in clinical practice.
    Wilson SL; Poulter NR
    Br J Biomed Sci; 2001; 58(4):248-51. PubMed ID: 11788004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk scoring in the assessment of cardiovascular risk.
    Beswick A; Brindle P
    Curr Opin Lipidol; 2006 Aug; 17(4):375-86. PubMed ID: 16832160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk stratification].
    Martínez Réding J
    Arch Cardiol Mex; 2006; 76 Suppl 2():S176-81. PubMed ID: 17017096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cardiovascular risk.
    Cooney MT; Cooney HC; Dudina A; Graham IM
    Curr Hypertens Rep; 2010 Oct; 12(5):384-93. PubMed ID: 20838940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.